208 related articles for article (PubMed ID: 22586485)
1. The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria.
Sun Q; Jiang S; Li X; Huang X; Xie K; Cheng D; Chen J; Ji S; Wen J; Zhang M; Zeng C; Liu Z
PLoS One; 2012; 7(5):e36654. PubMed ID: 22586485
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic Features that Predict Transplant Glomerulopathy Progression in a Chinese Cohort.
Li X; Chen J; Cheng D; Wang W; Xie K; Zhang M; Xu F; Wen J; Tang Z
Am J Nephrol; 2019; 49(6):425-434. PubMed ID: 30991390
[TBL] [Abstract][Full Text] [Related]
3. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
[TBL] [Abstract][Full Text] [Related]
4. Glomerulonephritis is the major cause of proteinuria in renal transplant recipients: histopathologic findings of renal allografts with proteinuria.
Chung J; Park SK; Park JS; Kim SC; Han DJ; Yu E
Clin Transplant; 2000 Oct; 14(5):499-504. PubMed ID: 11048996
[TBL] [Abstract][Full Text] [Related]
5. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
[TBL] [Abstract][Full Text] [Related]
6. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.
Höcker B; Tönshoff B
Paediatr Drugs; 2009; 11(6):381-96. PubMed ID: 19877724
[TBL] [Abstract][Full Text] [Related]
9. Proteinuria among primarily sirolimus treated live-donor renal transplant recipients' long-term experience.
Hamdy AF; Bakr MA; Ghoneim MA
Exp Clin Transplant; 2010 Dec; 8(4):283-91. PubMed ID: 21143093
[TBL] [Abstract][Full Text] [Related]
10. Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy.
Toki D; Inui M; Ishida H; Okumi M; Shimizu T; Shirakawa H; Omoto K; Unagami K; Setoguchi K; Koike J; Honda K; Yamaguchi Y; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():20-5. PubMed ID: 26970313
[TBL] [Abstract][Full Text] [Related]
11. Effect of histological damage on long-term kidney transplant outcome.
Nankivell BJ; Fenton-Lee CA; Kuypers DR; Cheung E; Allen RD; O'Connell PJ; Chapman JR
Transplantation; 2001 Feb; 71(4):515-23. PubMed ID: 11258430
[TBL] [Abstract][Full Text] [Related]
12. Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.
Aubert O; Higgins S; Bouatou Y; Yoo D; Raynaud M; Viglietti D; Rabant M; Hidalgo L; Glotz D; Legendre C; Delahousse M; Shah N; Sis B; Campbell P; Mengel M; Jouven X; Duong Van Huyen JP; Lefaucheur C; Loupy A
J Am Soc Nephrol; 2019 Apr; 30(4):625-639. PubMed ID: 30872323
[TBL] [Abstract][Full Text] [Related]
13. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
14. Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients.
Sutherland SM; Li L; Sigdel TK; Wadia PP; Miklos DB; Butte AJ; Sarwal MM
Kidney Int; 2009 Dec; 76(12):1277-83. PubMed ID: 19812540
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria in cyclosporine-treated renal transplant recipients.
Vathsala A; Verani R; Schoenberg L; Lewis RM; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1990 Jan; 49(1):35-41. PubMed ID: 2301024
[TBL] [Abstract][Full Text] [Related]
16. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
Nauta FL; Bakker SJ; van Oeveren W; Navis G; van der Heide JJ; van Goor H; de Jong PE; Gansevoort RT
Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological analysis of transplant glomerulopathy cases.
Shimizu T; Ishida H; Shirakawa H; Omoto K; Tsunoyama K; Iida S; Tanabe K; Yamaguchi Y
Clin Transplant; 2009 Aug; 23 Suppl 20():39-43. PubMed ID: 19594595
[TBL] [Abstract][Full Text] [Related]
18. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival.
Cosio FG; Frankel WL; Pelletier RP; Pesavento TE; Henry ML; Ferguson RM
Am J Kidney Dis; 1999 Oct; 34(4):731-8. PubMed ID: 10516356
[TBL] [Abstract][Full Text] [Related]
19. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
[TBL] [Abstract][Full Text] [Related]
20. Renal transplant patients with preformed anti-HLA antibodies: early biopsy findings and clinical outcomes.
Sousa MV; Zollner RL; Mazzali M
J Bras Nefrol; 2019 Sep; 42(2):201-210. PubMed ID: 31528982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
